During hypoxia, CAFs produce lactic acid, which is released by monocarboxylate transporter4 (MCT4) by activating the TGF-β1/p38MAPK/MMP2/9 signaling axis, and enters the cell with the help of the cancer cell monocarboxylate transporter 1 (MCT1). Here, SLC16A1 is linked to cancer.